Heartflow (NASDAQ:HTFL) Insider Campbell Rogers Sells 12,156 Shares of Company Stock

Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 12,156 shares of the business’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $50.15, for a total value of $609,623.40. Following the completion of the transaction, the insider directly owned 16,962 shares of the company’s stock, valued at approximately $850,644.30. The trade was a 41.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Campbell Rogers also recently made the following trade(s):

  • On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total value of $668,756.57.
  • On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $46.39, for a total value of $563,963.23.
  • On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The shares were sold at an average price of $46.39, for a total value of $1,122,081.32.
  • On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total transaction of $1,316,554.33.
  • On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total transaction of $987,052.30.

Heartflow Trading Down 2.7%

Shares of NASDAQ:HTFL traded down $1.26 during trading on Thursday, reaching $44.63. The stock had a trading volume of 1,279,655 shares, compared to its average volume of 1,615,683. Heartflow, Inc. has a one year low of $20.13 and a one year high of $60.65. The company has a market capitalization of $3.92 billion, a P/E ratio of -48.51 and a beta of 2.50. The firm’s 50-day simple moving average is $51.84 and its 200 day simple moving average is $35.47.

Heartflow (NASDAQ:HTFL – Get Free Report) last posted its quarterly earnings data on Thursday, November 12th. The company reported ($0.03) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.15. Heartflow had a negative net margin of 33.11% and a negative return on equity of 20.53%. The firm had revenue of $72.86 million during the quarter. During the same quarter last year, the firm earned ($0.27) EPS. Equities research analysts forecast that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have issued reports on HTFL shares. Piper Sandler reaffirmed an “overweight” rating and issued a $64.00 price target (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. UBS Group initiated coverage on Heartflow in a research report on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 price objective for the company. JPMorgan Chase & Co. boosted their target price on Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a research note on Friday, August 14th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Wells Fargo & Company increased their price target on Heartflow from $39.00 to $70.00 and gave the company an “overweight” rating in a research note on Friday, November 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $60.12.

Get Our Latest Stock Analysis on Heartflow

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in HTFL. XXEC Inc. purchased a new position in Heartflow in the 2nd quarter worth $2,524,764,000. BlackRock Inc. purchased a new position in Heartflow during the 2nd quarter worth approximately $152,502,000. Bamco Inc. NY acquired a new stake in Heartflow during the 2nd quarter valued at approximately $94,625,000. Jupiter Topco LLC purchased a new stake in shares of Heartflow in the 2nd quarter valued at $70,983,000. Finally, Janus Henderson Group PLC boosted its holdings in shares of Heartflow by 152.0% in the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock valued at $53,063,000 after acquiring an additional 1,315,416 shares during the last quarter.

Heartflow Company Profile

(Get Free Report)

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.

Featured Stories

Insider Buying and Selling by Quarter for Heartflow (NASDAQ:HTFL)

Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.